Watchlist Price Alert

Bicycle Therapeutics (BCYC)

NASDAQ: BCYC · Real-Time Price · USD

8.04

-0.07 (-0.86%)

At close: May 14, 2025, 3:59 PM

8.03

-0.12%

Pre-market: May 15, 2025, 06:01 AM EDT

Bicycle Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	35.27M	26.98M	14.46M	11.7M	10.39M	13.8M	7.14M	2.06M	n/a
Cost of Revenue	7.16M	6.47M	3.69M	44.88M	33.15M	25.54M	20.76M	11.87M	269.29K
Gross Profit	28.11M	20.51M	10.78M	-33.18M	-22.76M	-11.74M	-13.63M	-9.81M	-269.29K
Operating Income	-209.87M	-189.95M	-116.65M	-65.62M	-51.96M	-26.3M	-21.75M	-16.21M	-13.49M
Interest Income	34.28M	14M	5.76M	120K	683K	814K	169K	50K	8K
Pretax Income	-173.8M	-179.21M	-114.24M	-68.48M	-51.73M	-30.86M	-22.24M	-16.28M	-13.53M
Net Income	-169.03M	-180.66M	-112.72M	-66.82M	-51.01M	-30.61M	-21.85M	-16.26M	-13.51M
Selling & General & Admin	71.46M	59.83M	49.51M	32.44M	29.2M	14.56M	8.12M	6.41M	3.45M
Research & Development	172.97M	156.5M	81.61M	44.88M	33.15M	25.54M	20.76M	11.87M	9.77M
Other Expenses	n/a	594K	n/a	n/a	n/a	-5.38M	-665K	-119K	n/a
Operating Expenses	245.15M	216.92M	131.12M	77.31M	62.35M	40.1M	28.88M	18.27M	13.22M
Interest Expense	1.73M	3.26M	3.34M	2.98M	457K	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-325.11K
Cost & Expenses	245.15M	216.92M	131.12M	77.31M	62.35M	40.1M	28.88M	18.27M	13.49M
Income Tax Expense	-4.76M	1.46M	-1.52M	-1.66M	-724K	-254K	-396K	-23K	-20.94K
Shares Outstanding (Basic)	582.08M	35.59M	29.66M	25.06M	19.15M	11.05M	13.29M	13.29M	17.7M
Shares Outstanding (Diluted)	58.21M	35.59M	29.66M	25.06M	19.15M	11.05M	13.29M	13.29M	17.7M
EPS (Basic)	-0.29	-5.08	-3.8	-2.67	-2.66	-2.77	-1.64	-1.22	-0.76
EPS (Diluted)	-2.9	-5.08	-3.8	-2.67	-2.66	-2.77	-1.64	-1.22	-0.76
EBITDA	-164.89M	-183.4M	-112.96M	-64.08M	-50.39M	-30.03M	-21.49M	-15.88M	-13.26M
EBIT	-172.07M	-175.94M	-116.65M	-65.5M	-51.28M	-30.86M	-22.24M	-16.21M	-13.53M
Depreciation & Amortization	7.18M	6.55M	3.69M	1.41M	1.29M	963.97K	710.8K	335.56K	269.29K